BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17287158)

  • 1. Hepatoma-related gamma-glutamyl transferase in laboratory or clinical diagnosis of hepatocellular carcinoma.
    Yao DF; Dong ZZ
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):9-11. PubMed ID: 17287158
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical significance of hepatoma-specific band of serum gamma-glutamyl transferase.
    Xu KC; Meng XY; Shi YC; Ge ZJ; Ye L; Yu ZJ; Yang DM
    Chin Med J (Engl); 1986 Jul; 99(7):583-6. PubMed ID: 2879711
    [No Abstract]   [Full Text] [Related]  

  • 3. Reappraisal of diagnostic significance of a hepatoma-specific band of serum gamma-glutamyl transferase.
    Xu KC; Shi YC; Meng XY; Wei Q
    Chin Med J (Engl); 1990 Mar; 103(3):228-32. PubMed ID: 1973381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
    Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detecting the gamma-glutamyltransferase mRNA-H in the peripheral blood of primary hepatocellular carcinoma patients].
    Han GQ; Qin CY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):630-1. PubMed ID: 14572351
    [No Abstract]   [Full Text] [Related]  

  • 6. In the new area of noninvasive markers of hepatocellular carcinoma.
    Paradis V; Bedossa P
    J Hepatol; 2007 Jan; 46(1):9-11. PubMed ID: 17112623
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha-2 macroglobulin: an additional marker for diagnosis of hepatocellular carcinoma.
    Kar P; Gandhi BM; Irshad M; Gupta H; Tandon BN
    J Assoc Physicians India; 1987 Apr; 35(4):288-9. PubMed ID: 2443479
    [No Abstract]   [Full Text] [Related]  

  • 8. [Molecular markers for early diagnosis of hepatocellular carcinoma].
    Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific molecular markers in hepatocellular carcinoma.
    Yao DF; Dong ZZ; Yao M
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):241-7. PubMed ID: 17548245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amplification of peripheral blood insulin-like growth factor II-mRNA and its clinical significance in the diagnosis of hepatocellular carcinoma].
    Yao DF; Dong ZZ; Liu YH; Zhao L; Huang JF; Meng XY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Nov; 11(11):695-6. PubMed ID: 14636457
    [No Abstract]   [Full Text] [Related]  

  • 11. The copper/zinc ratio in patients with hepatocellular carcinoma.
    Ebara M; Fukuda H; Saisho H
    J Gastroenterol; 2003; 38(1):104-5. PubMed ID: 12560932
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum golgi phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
    Li X; Wu K; Fan D
    Hepatology; 2009 Nov; 50(5):1682. PubMed ID: 19739256
    [No Abstract]   [Full Text] [Related]  

  • 13. [Screening of serum biomarkers in hepatocellular carcinoma by SELDI technique: a preliminary study].
    Yao DK; Zhu L; Wang WJ; Song ST
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):298-9. PubMed ID: 17456321
    [No Abstract]   [Full Text] [Related]  

  • 14. [Surgical therapy of hepatic fibrolamellar carcinoma].
    Meriggi F; Forni E
    Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor markers for hepatoma and carcinoma of biliary tract].
    Higashino K
    Rinsho Byori; 1985 Aug; 33(8):861-71. PubMed ID: 2416966
    [No Abstract]   [Full Text] [Related]  

  • 16. Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma.
    Marsh JW; Casavilla A; Iwatsuki S; Dvorchik I; Subotin M; Balan V; Rakela J; Subbotin V; Popechitelev EP
    Hepatology; 1997 Dec; 26(6):1689-91. PubMed ID: 9398022
    [No Abstract]   [Full Text] [Related]  

  • 17. Ratio of serum ornithine carbamoyltransferase to alanine aminotransferase as a potent indicator for hepatocellular carcinoma.
    Murayama H; Fukuda Y; Tsunekawa S; Ikemoto M; Nagata A
    Clin Biochem; 2007 Sep; 40(13-14):1077-80. PubMed ID: 17570354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive markers for postsurgical recurrence of hepatocellular carcinoma.
    Gao ZH
    J Surg Oncol; 2005 Dec; 92(4):274-5. PubMed ID: 16299794
    [No Abstract]   [Full Text] [Related]  

  • 19. Gamma-glutamyl transpeptidase messenger RNA may serve as a diagnostic aid in hepatocellular carcinoma.
    Jeng KS; Sheen IS; Tsai YC
    Br J Surg; 2001 Jul; 88(7):986-7. PubMed ID: 11442532
    [No Abstract]   [Full Text] [Related]  

  • 20. [The application of serum tumor markers in the diagnosis of hepatocellular carcinoma].
    Liao HY
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):379-80. PubMed ID: 15918977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.